Tag: DWI
Confidence in surface modification bolstered by one-year COATING trial results
This advertorial is sponsored by WallabyPhenox.
New clinical data from the COATING randomised controlled trial (RCT)—presented for the first time at the 2026 LINNC Paris...
Hyperfine announces US FDA clearance of first Optive AI software update...
Hyperfine has announced that it has received US Food and Drug Administration (FDA) clearance for a new multi-direction diffusion-weighted imaging (DWI) software sequence within...
